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Mouse Model of Touch-Evoked Itch (Alloknesis)
Tasuku Akiyama1, Mirela Iodi Carstens1, Akihiko Ikoma2, Ferda Cevikbas2, Martin Steinhoff2 and Earl Carstens1
Lightly touching normal skin near a site of itch can elicit itch sensation, a phenomenon known as alloknesis.
To investigate the neural mechanisms of alloknesis, we have developed an animal model. Low-threshold
mechanical stimulation of the skin normally does not elicit any response in naive C57/BL6 mice. Following acute
intradermal (i.d.) injection of histamine in the rostral back, mechanical stimulation 7mm from the injection site
elicited discrete hindlimb scratch bouts directed toward the stimulus. This began at 10minutes and peaked
20–40minutes post histamine injection, declining over the next hour. Histamine itself elicited bouts of
scratching not associated with the mechanical stimulus, which ceased after 30minutes. Histamine- and touch-
evoked scratching was inhibited by the m-opiate antagonist naltrexone. Touch-evoked scratching was observed
following i.d. 5-HT (5-hydroxytryptamine), a protease-activated receptor (PAR)-4 agonist, and an MrgprC11
agonist BAM8-22, but not chloroquine or a PAR-2 agonist. The histamine H1 receptor antagonist terfenadine
prevented scratching and alloknesis evoked by histamine, but not 5-HT, a PAR-4 agonist or an MrgprC11 agonist.
In mice with experimental dry skin, there was a time-dependent increase in spontaneous and touch-evoked
scratching. This animal model appears to be useful to investigate neural mechanisms of itch and alloknesis.
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INTRODUCTION
Chronic itch associated with dermatitis and systemic diseases
considerably decreases the quality of life in patients (Ikoma
et al., 2006). A potential mechanism underlying chronic itch
is sensitization of itch-signaling pathways. In lesional skin
of atopic dermatitis patients, pruritogens elicit stronger itch
(hyperknesis) and noxious stimuli elicit itch instead of pain
(Ikoma et al., 2004a, b; Hosogi et al., 2006). Moreover,
innocuous mechanical stimuli also frequently elicit itch
sensation in patients suffering from chronic itch (Wahlgren
et al., 1991). When delivered within a region of normal skin
surrounding a site of experimental itch induced by intrader-
mal (i.d.) injection of histamine, innocuous mechanical
stimuli elicit itch (Simone et al., 1991; Heyer et al., 1997),
a phenomenon called itchy skin or alloknesis (LaMotte,
1992). Alloknesis may reflect a central mechanism in which
activation of low-threshold mechanoreceptors excites sensi-
tized itch-signaling neurons in the spinal cord. However, this
has not yet been tested because of the lack of an animal
model for alloknesis.
Itch is defined as an unpleasant sensation that provokes the
desire to scratch. The close relationship between itch and
scratch has been exploited in rodent models in which
hindlimb scratching is used to assess itch (Carstens and
Kuraishi, 2004). Intradermal injection of histamine, 5-hydro-
xytryptamine (5-HT), agonists of protease-activated receptors
protease-activated receptor (PAR)-2 and PAR-4, the MrgprA3
agonist chloroquine, or MrgprC11 agonist BAM8-22 elicits
bouts of directed hindlimb scratching that are attenuated by
m-opioid antagonists but not by morphine (Liu et al., 2009;
Akiyama et al., 2009b, c, 2010a, c). These results are
consistent with the antipruritic effects of m-antagonists (Heyer
et al., 1997) and the well-known ability of m-agonists to
induce or enhance itch, further validating the rodent itch
models. In the present study, we investigated whether
innocuous mechanical stimuli delivered to skin adjacent to
a site of pruritogenic stimulation could elicit scratching.
We additionally wished to determine whether innocuous
mechanical stimuli elicit scratching in a model of chronic dry
skin itch. Repeated treatment of murine skin with acetone–/
diethylether–water (AEW) induces dry skin characterized by
increased transepidermal water loss, hyperplasia, and in-
creased spontaneous scratching that was attenuated by m-
antagonists (Akiyama et al., 2010b, d). Moreover, there was
a differential enhancement of scratching elicited by certain
pruritogens (5-HT, PAR-2 agonist), accompanied by en-
hanced responses of primary sensory dorsal root ganglion
(Akiyama et al., 2010b) and second-order dorsal horn
neurons (Akiyama et al., 2011). We hypothesized that the
chronic dry skin itch is accompanied by alloknesis, such that
innocuous mechanical stimuli delivered outside the peri-
meter of the dry skin area would elicit scratching behavior.
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RESULTS
Alloknesis following i.d. histamine injection
Histamine (271 nmol) elicited bouts of scratching that
declined over a 30-minute period (Figure 1, open bars).
These scratch bouts occurred independently of mechanical
stimuli and presumably reflect ongoing itch from the
histamine injection. Vehicle (saline) injection elicited very
few scratch bouts (Figure 1, filled bars). Before histamine
injection, von Frey stimulation never elicited any scratch
responses (Supplementary Video S1 online). Following i.d.
histamine injection, von Frey stimuli did not elicit scratching
until 10minutes post injection, at which time the alloknesis
score started to increase (Figure 1, ). Supplementary Video
S2 online shows an example of a touch-evoked scratch bout.
The alloknesis score reached a maximal level during the 15-
to 45-minute period post histamine injection, and then
gradually declined to zero over 2 hours. Following vehicle
(saline) injection, von Frey stimuli never elicited any scratch
bouts during this period (Figure 1, ).
It is noteworthy that the time courses of histamine-evoked
scratch bouts and alloknesis differed, with the latter peaking
after histamine-evoked scratching behavior had ceased.
During the first 30minutes post histamine injection when
scratching was observed, it is important to note that the von
Frey stimulus was only applied at times when no histamine-
related scratch bouts occurred. However, because the
histamine-evoked scratch bouts could potentially interfere
with von Frey–evoked scratch responses, in subsequent
experiments we began alloknesis testing 30minutes after
injection of the pruritogen when the occurrence of histamine-
evoked scratch bouts had ceased.
Naltrexone attenuates histamine-evoked alloknesis and
spontaneously occurring scratch bouts
The mean histamine-evoked alloknesis score over the period
from 30 to 60minutes following i.d. histamine injection, and
mean number of histamine-evoked scratch bouts, is shown in
Figure 2a and b, respectively (black bars). Pretreatment with
naltrexone resulted in a significant reduction in the mean
alloknesis score (Figure 2a, gray bar) and number of spon-
taneously occurring scratch bouts (Figure 2b, gray bar).
Pretreatment with systemic administration of saline (vehicle)
did not affect the alloknesis score or number of spontaneous
scratch bouts elicited by i.d. histamine injection (Figure 2a,b,
white bars). Figure 2a shows the average of the sum of the
alloknesis score over 30–60minutes followed by histamine
injection. The i.d. injection of saline resulted in an alloknesis
score of 0 (Figure 2a) and evoked a minimal number of
scratch bouts (Figure 2b, striped bar).
Scratching and alloknesis elicited by other pruritogens
We additionally assessed scratching and alloknesis following
i.d. injection of a variety of pruritogens. Figures 3a and b show
dose–response curves of scratch bouts and alloknesis scores,
respectively, elicited by various pruritogens. Histamine, 5-HT,
the PAR-4 agonist, and BAM8-22 each elicited dose-
dependent alloknesis, whereas the PAR-2 agonist and chloro-
quine elicited weak or no alloknesis. The time courses of
alloknesis elicited by these agents at the intermediate or high
dose are shown in Figure 3c,d. The PAR-4 agonist, 5-HT, and
BAM8-22 elicited alloknesis that peaked around 40–45min-
utes post injection and declined by 60–120minutes. Saline did
not elicit any alloknesis and minimal scratching.
Histamine-dependent and -independent types of itch were
accompanied by alloknesis. Pretreatment with the H1 hista-
mine receptor antagonist terfenadine almost completely
abolished histamine-evoked alloknesis (Figure 4a) and scratch-
ing (Figure 4b). In contrast, pretreatment with terfenadine
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Figure 1. Time course of scratching and alloknesis elicited by histamine.
Bars: mean number of scratch bouts (right-hand y axis) following histamine
(&) or vehicle (’). Line graphs: mean alloknesis score (left-hand y axis)
following histamine ( ) or vehicle ( ). Error bars are SEM (n¼6 per group).
Following intradermal injection of histamine (271 nmol per 10 ml; open bars
and ) or saline (vehicle; filled bars and ) in the nape of the neck, the
mouse was placed into the recording arena and videotaped for 30minutes. At
5-minute intervals, an innocuous von Frey filament (bending force 0.7mN)
was applied three times at separate sites oriented radially at a distance of
7mm from the histamine injection site, and the presence or absence of a
hindlimb scratch bout following each stimulus was noted (maximum
alloknesis score¼3). The number of histamine- or vehicle-evoked hindlimb
scratch bouts directed to the injection site (not associated with the von Frey
stimulus) was counted after the experiment by reviewing the videotape.
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Figure 2. Effects of naltrexone on alloknesis and scratch evoked by
histamine. (a) Bar graph of the mean sum of alloknesis score over
30–60minutes after histamine (His) injection. The striped and black bars
show, respectively, the sum of the alloknesis score evoked by saline (Sal) and
His (271 nmol per 10 ml). The white and gray bars show the sum of score for
alloknesis evoked by His when preceded by subcutaneous Sal or by
naltrexone (Nal; 1mg kg1), respectively. (b) Same as in a for mean scratch
bouts over 30minutes. Error bars are SEM. *Po0.05, significant difference
from Sal group (n¼6 per group). #Po0.05, significant difference from
Hisþ Sal group (n¼6 per group).
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failed to reduce the mean alloknesis score (Figure 4a) or
number of pruritogen-evoked scratch bouts (Figure 4b) follow-
ing i.d. injection of 5-HT, the PAR-4 agonist, or BAM8-22.
Alloknesis in AEW-treated mice
Transepidermal water loss increased significantly on the
first day of AEW treatment and reached a plateau by day 3
(Figure 5a, K). Spontaneous scratching behavior increased
significantly by treatment day 3 (Figure 5b, K) and continued
to gradually rise. Alloknesis elicited by weak mechanical
stimulation at the perimeter of the AEW treatment area
increased significantly by day 4 and appeared to reach a
plateau (Figure 5c, K). There were no significant changes in
any of these measures in the control W treatment group
(Figure 5a–c, &).
DISCUSSION
Innocuous mechanical stimuli that normally do not elicit a
behavioral response in C57/BL6 mice elicited scratch bouts
when delivered following i.d. application of the pruritogens
histamine, 5-HT, the PAR-4 agonist, and BAM8-22. Similarly,
following local application of histamine, 5-HT, or BAM8-22
in humans, innocuous mechanical stimuli elicit itch, a
phenomenon called alloknesis (Simone et al., 1991; Heyer
et al., 1997; Weisshaar et al., 2004; Sikand et al., 2011). The
incidence of mechanical stimulus–evoked scratching
peaked at 10–40minutes following histamine injection and
declined after that. Post histamine injection, mechanically
evoked scratching in mice was significantly attenuated by the
m-opioid antagonist naltrexone, consistent with the ability of
another antagonist, naloxone, to reduce alloknesis in humans
(Heyer et al., 1997) and supporting the view that touch-
evoked scratching represents a new animal model of
alloknesis. Innocuous mechanical stimulation also elicited
scratching when delivered at the edge of a region of AEW
treatment in mice, suggesting the presence of alloknesis in
this animal model of chronic dry skin itch.
It has been recently reported that Mrgprs present in subsets
of small-diameter sensory neurons have an important role in
itch. MrgprA3 and MrgprC11 are activated by chloroquine
and BAM8-22, respectively (Liu et al., 2009). The subpopula-
tion of BAM8-22-responsive dorsal root ganglion neurons is
part of the subpopulation of chloroquine-responsive dorsal
root ganglion neurons. Chloroquine failed to elicit alloknesis,
whereas BAM8-22 elicited alloknesis (Figure 3), suggesting
that these agonists activate separate itch-signaling pathways.
In support of this, BAM8-22-elicited signaling requires
phospholipase C, whereas chloroquine-elicited signaling
requires Gbg (Wilson et al., 2011).
The PAR-2 agonist SLIGRL-NH2 failed to elicit alloknesis
(Figure 3). It was recently reported that SLIGRL-NH2 activates
PAR-2, as well as MrgprC11 (Liu et al., 2011). SLIGRL-NH2
differentially elicits hyperalgesia via PAR-2 rather than
MrgprC11, whereas it elicits scratching via MrgprC11 rather
than PAR-2. Consistent with this, we observed that the
MrgprC11 agonist BAM8-22 elicited scratching with accom-
panying alloknesis (Figure 3). We speculate that the inability
of the PAR-2 agonist SLIGRL-NH2 to elicit alloknesis is due to
its hyperalgesic action mediated via PAR-2. Consistent with
this idea, it was previously reported that histamine failed to
elicit alloknesis when injected into an area of capsaicin-
evoked allodynia (Brull et al., 1999).
Recent studies indicate that there are separate mechanisms
and pathways for histamine-dependent itch and other types of
itch (Steinhoff et al., 2003; Davidson and Giesler, 2010) In
particular, i.d. insertion of cowhage spicules, which contain
proteases (mucunain), induce a largely histamine-independent
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Figure 3. Scratching and alloknesis elicited by different pruritogens.
(a) Dose–response curve for scratch bouts (assessed over 30minutes) elicited
by intradermal injection of pruritogens indicated in the legend. Error bars:
SEM (n¼6 per group). (b) Dose–response curve for alloknesis score elicited by
the same pruritogens. (c) Time course of alloknesis for histamine (271 nmol
per 10 ml), protease-activated receptor (PAR)-2 agonist SLIGRL-NH2 (76 nmol
per 10 ml), PAR-4 agonist AYPGKF-NH2 (146 nmol per 10 ml), and saline
vehicle. (d) Time course of alloknesis for 5-hydroxytryptamine (5-HT; 47 nmol
per 10 ml), chloroquine (193 nmol per 10 ml), and BAM8-22 (50 nmol per
10ml).
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Figure 4. Effects of terfenadine on alloknesis and scratching evoked by four
pruritogens. (a) Bar graph of the mean alloknesis score during the time period
30–60minutes after injection of the following: histamine (His; 271 nmol per
10ml), 5-hydroxytryptamine (5-HT; 47 nmol per 10 ml), protease-activated
receptor (PAR)-4 agonist AYPGKF-NH2 (146 nmol per 10 ml), BAM8-22
(50 nmol per 10ml). Graph shows the alloknesis scores evoked by each
pruritogen without (open bars) or following pretreatment with terfenadine
(filled bars, 30mg kg1), respectively. (b) Same as in a for mean scratch bouts
over 30minutes. Error bars are SEM. *Po0.05, significant difference from
control group (n¼6 per group).
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type of itch (Johanek et al., 2007). Current evidence also
suggests that histamine and cowhage may excite largely
separate populations of primary afferents, namely mechani-
cally insensitive C afferents and polymodal nociceptors,
respectively (Schmelz et al., 1997; Johanek et al., 2008;
Namer et al., 2008). Moreover, histamine and cowhage excite
separate populations of primate spinothalamic tract neurons
(Davidson et al., 2007). These findings support the notion of
separate, histamine-dependent and histamine-independent
itch pathways. We were interested to determine whether
histamine-dependent and -independent types of itch are
accompanied by alloknesis. 5-HT, the PAR-4 agonist, and
BAM8-22 each elicited scratching and alloknesis. The
alloknesis evoked by these agents was not affected by
pretreatment with the H1 histamine receptor terfenadine. In
contrast, histamine-evoked scratching and alloknesis were
significantly attenuated by the H1 antagonist (Figure 4). This
result is consistent with human psychophysical data showing
that an H1 histamine receptor antagonist failed to reduce the
BAM8-22-elicited itch sensations and allokensis (Sikand et al.,
2011). Our data indicate that 5-HT, the PAR-4 agonist, and
BAM8-22 elicit itch and alloknesis in a histamine-indepen-
dent manner.
The duration of alloknesis in mice appeared to be longer
compared with histamine-evoked alloknesis in humans,
which peaksB12minutes post injection and declines within
about 40minutes (Simone et al., 1991). In the latter study, it
was shown that the development of alloknesis was delayed
by skin cooling (Simone et al., 1991). In our experiments, the
mice were freely able to scratch at and around the injection
site, whereas in the human studies the magnitude of itch
sensation was rated in the absence of scratching. We suggest
that scratching may have delayed the build-up of alloknesis
in our studies to result in a longer time course.
One potential mechanism underlying alloknesis is the
sensitization of itch pathways to touch. We previously
showed that a subpopulation of neurons in the superficial
doral horn responds to i.d. injection of pruritogens over a
time course consistent with scratching behavior (Akiyama
et al., 2009a, b), representing candidate itch-signaling neu-
rons. We are currently investigating whether i.d. injection of
histamine or other pruritogens enhances low-threshold
mechanically evoked responses of pruritogen-responsive
dorsal horn neurons in mice. We hypothesize that acute
and chronic itch conditions might sensitize either peripheral
mechanosensitive afferents, and/or spinal itch-signaling
neurons, to increase touch-evoked activity in the itch
pathway.
Alloknesis was also observed in our present experimental
model of chronic dry skin pruritus. The onset of alloknesis was
delayed relative to the onset of spontaneous scratching. The
increase in spontaneous scratching may reflect sensitization of
itch-signlaing pathways. We recently reported that in mice
receiving similar hindpaw AEW treatment, lumbar superficial
dorsal horn neurons recorded ipsilateral to the dry skin
treatment exhibited significantly heightened spontaneous
activity and pruritogen-evoked responses compared with
neurons ipsilateral to the control (water-treated) or untreated
hindpaw (Akiyama et al., 2011). However, we did not observe
enhancement of low-threshold mechanically evoked re-
sponses of neurons ipsilateral to the hindpaw AEW treatment
(Akiyama et al., 2011). In the present study, alloknesis was
only elicited by stimulation at the border of the dry
skin–treated area, but not within the treatment area. In the
electrophysiological study, neuronal receptive fields were
within the hindpaw dry skin area where mechanical stimula-
tion would not be expected to elicit enhanced responses.
In conclusion, we have developed a murine model of
alloknesis, which to our knowledge has not been previously
reported. Innocuous mechanical stimulation of skin adjacent
to a site of acute itch, or chronic dry skin treatment on the
rostral back, elicited scratching behavior in both histamine-
dependent and -independent manner. This model should
prove useful in future studies that investigate the mechanisms
and pathways underlying itch.
MATERIALS AND METHODS
Experiments were conducted using adult C57BL/6 mice (Harlan,
Oxnard, CA; 19–32 g body weight) under a protocol approved by the
UC Davis Animal Care and Use Committee.
Behavior
The fur on the nape of the neck was shaved and mice were
habituated to a Plexiglas recording arena with a transparent cover 1
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Figure 5. Time-dependent changes in scratch bouts, transepidermal water loss (TEWL), and alloknesis score in dry skin mice. The dry skin was developed
by treating with acetone–diethylether–water (AEW) twice a day for 12 days. (a) TEWL was measured on days 0, 1, 3, 5, 8, 10, and 12. Black circle and
white square show, respectively, AEW-treated and water (W)-treated groups. (b) Same as in a for spontaneous scratching. (c) Same as in a for alloknesis score.
Error bars are SEM. *Po0.05, significant difference from day 0.
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week before testing. On the test day, the animal received an i.d.
microinjection of 10 ml of one of the following: vehicle (isotonic
saline), histamine (54, 190, 271 nmol; Sigma-Aldrich, St Louis, MO),
PAR-2 agonist SLIGRL-NH2 (53, 76, 152 nmol; Quality Controlled
Biochemicals, Hopkinton, MA), PAR-4 agonist AYPGKF-NH2 (14,
73, 146 nmol; Quality Controlled Biochemicals), 5-HT (0.47, 4.7,
47 nmol; Alfa Aesar, Ward Hill, MA), chloroquine (19, 193,
387 nmol; Sigma-Aldrich), or BAM8-22 (0.5, 5, 50 nmol; Genemed
Synthesis, San Antonio, TX). Briefly, microinjections were adminis-
tered i.d. in the nape of the neck using a 30-G needle attached to a
Hamilton microsyringe by PE-50 tubing (Hamilton, Reno, NV).
Immediately following the i.d. microinjection, mice were placed
into the arena and videotaped from above. In the first experiment,
the animal was tested for alloknesis at 5-minute intervals, starting
5minutes post injection. In the remainder of the experiments,
investigators left the room for 30minutes and then returned to test for
alloknesis, starting 30minutes post injection.
Alloknesis was assessed as follows: at 5-minute intervals, the
mouse received three separate innocuous mechanical stimuli
delivered using a von Frey filament (bending force: 0.7mN) at
separate, randomly selected sites oriented radially 7mm away from
the injection site. The 0.7mN von Frey filament was selected
because it never elicited scratch bouts in naive mice, and was the
minimum strength to elicit scratch bouts when delivered to skin
surrounding the site of histamine injection or dry skin treatment. The
presence or absence of a positive response, i.e., a hindlimb scratch
bout directed to the site of mechanical stimulation, was noted for
each stimulus before the next one was given. The alloknesis score
was the total number of positive responses elicited by the three
stimuli, i.e., 0, 1, 2, or 3. The sequence was repeated at 5-minute
intervals out to 60minutes post injection, and again at 90 and
120minutes post injection. In many experiments, an overall
alloknesis score per 30minutes was calculated as the sum of
individual alloknesis scores at each 5-minute interval over the 30-
minute period beginning 30minutes post injection.
In one set of experiments, we tested the effect of the m-opiate
antagonist naltrexone on scratching and alloknesis. Naltrexone
(1mg kg1 subcutaneously, DuPont, Garden, NY) or saline was
administered 10minutes before administering the i.d. microinjection
of histamine as described in our recent study (Akiyama et al., 2009c).
In another set of experiments, we tested the effect of the H1
histamine receptor antagonist terfenadine on scratching and allokn-
esis. Terfenadine (30mg kg1 intraperitoneal, Sigma) was adminis-
tered 30minutes before the i.d. microinjection of histamine, 5-HT,
the PAR-4 agonist, or BAM8-22.
Videotapes were played back and the number of scratch bouts
counted at 5-minute intervals over the 30-minute recording period
by two independent observers blinded to the treatment. A scratch
bout is defined as one or more rapid back-and-forth motions of the
hindpaw directed to the site of injection, and ending with licking or
biting of the toes and/or placement of the hindpaw on the floor.
Between-group comparisons of counts of scratch bouts or alloknesis
scores were made by unpaired t-test with Po0.05 considered to be
significant.
Dry skin model
To induce chronic dry skin on the nape of the neck, we followed
a previously reported procedure (Miyamoto et al., 2002; Nojima
et al., 2003; Akiyama et al., 2010b). Briefly, a mixture of acetone and
diethylether (1:1) was applied to a circumscribed area (approxi-
mately 15 15mm2 spanning the midline) at the nape of the neck
for 15 seconds, followed immediately by applying distilled water for
30 seconds, twice daily for a maximum of 12 days (designated as
AEW treatment). Control mice were treated in the same manner with
application of water only for 45 seconds (designated as W
treatment). The animals’ toenails were clipped; mice were free to
direct hindlimb scratch movements to the treatment area such that
the skin was rubbed by the toes but not scratched. At 16–20 hours
after the second treatment on the 1st, 3rd, 5th, 8th, 10th, and 12th
treatment day, spontaneous behavior was recorded for 30minutes,
after which alloknesis testing was conducted in a manner similar to
that noted above. In pilot experiments, we determined that
application of von Frey stimuli within the AEW treatment area was
ineffective, whereas application at or outside the border of the AEW
treatment area elicited an approximately equivalent incidence of
positive scratch responses. For the data shown in Figure 4, von Frey
stimuli were applied on the border of the AEW (or W) treatment area
at three randomly selected sites. Transepidermal water loss was
measured by applying a Vapo Meter (Delfin Technologies, Kuopio,
Finland) to the skin for 10 seconds.
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